Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-154381
Filing Date
2025-07-02
Accepted
2025-07-02 08:25:36
Documents
5
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 6-K d27662d6k.htm 6-K 8677
2 EX-99.1 d27662dex991.htm EX-99.1 17684
3 EX-99.2 d27662dex992.htm EX-99.2 18039
4 GRAPHIC g27662g0618022340665.jpg GRAPHIC 1872
5 GRAPHIC g27662g39w89.jpg GRAPHIC 8587
  Complete submission text file 0001193125-25-154381.txt   54909
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251098394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)